SOLVENTUM CORPORATION Diluted Shares Outstanding (Weighted Average)
SOLVENTUM CORPORATION (SOLV) reported Diluted Shares Outstanding (Weighted Average) of 173.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-05
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 173.30M shares, a 1.08% decline year-over-year.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 175.50M shares, a 0.40% increase year-over-year.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 175.90M shares, a 0.74% increase year-over-year.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 175.40M shares, a 0.86% increase year-over-year.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for fiscal 2025 was 175.30M shares, a 0.92% increase from fiscal 2024.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for fiscal 2024 was 173.70M shares, a 0.58% increase from fiscal 2023.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for fiscal 2023 was 172.70M shares, a 0.00% change from fiscal 2022.
- SOLVENTUM CORPORATION weighted average number of shares outstanding, diluted for fiscal 2022 was 172.70M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | 173.30M shares 10-Q · filed 2026-08-05 | 174.40M shares 10-Q · filed 2026-08-05 | 174.90M shares derived: average of 3 quarters · filed 2026-08-05 | 175.03M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 175.50M shares 10-Q · filed 2026-05-05 | 175.70M shares derived: average of 2 quarters · filed 2026-05-05 | 175.60M shares derived: average of 3 quarters · filed 2026-05-05 | 175.50M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 175.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 175.65M shares derived: average of 2 quarters · filed 2026-02-27 | 175.50M shares derived: average of 3 quarters · filed 2026-08-05 | 175.30M shares 10-K · filed 2026-02-27 |
| 2025-09-30 | 175.40M shares 10-Q · filed 2025-11-06 | 175.30M shares derived: average of 2 quarters · filed 2026-08-05 | 175.10M shares 10-Q · filed 2025-11-06 | 175.00M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 175.20M shares 10-Q · filed 2026-08-05 | 175.00M shares 10-Q · filed 2026-08-05 | 174.87M shares derived: average of 3 quarters · filed 2026-08-05 | 174.63M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 174.80M shares 10-Q · filed 2026-05-05 | 174.70M shares derived: average of 2 quarters · filed 2026-05-05 | 174.43M shares derived: average of 3 quarters · filed 2026-05-05 | 174.20M shares derived: average of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | 174.60M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 174.25M shares derived: average of 2 quarters · filed 2026-02-27 | 174.00M shares derived: average of 3 quarters · filed 2026-02-27 | 173.70M shares 10-K · filed 2026-02-27 |
| 2024-09-30 | 173.90M shares 10-Q · filed 2025-11-06 | 173.70M shares derived: average of 2 quarters · filed 2025-11-06 | 173.40M shares 10-Q · filed 2025-11-06 | 173.20M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | 173.50M shares 10-Q · filed 2025-08-08 | 173.10M shares 10-Q · filed 2025-08-08 | 172.97M shares derived: average of 3 quarters · filed 2026-02-27 | 172.90M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | 172.70M shares 10-Q · filed 2025-05-09 | 172.70M shares derived: average of 2 quarters · filed 2026-02-27 | 172.70M shares derived: average of 3 quarters · filed 2026-02-27 | 172.70M shares derived: average of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | 172.70M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 172.70M shares derived: average of 2 quarters · filed 2026-02-27 | 172.70M shares derived: average of 3 quarters · filed 2026-02-27 | 172.70M shares 10-K · filed 2026-02-27 |
| 2023-09-30 | 172.70M shares 10-Q · filed 2024-11-08 | 172.70M shares derived: average of 2 quarters · filed 2024-11-08 | 172.70M shares 10-Q · filed 2024-11-08 | |
| 2023-06-30 | 172.70M shares 10-Q · filed 2024-08-09 | 172.70M shares 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | 172.70M shares 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 172.70M shares 10-K · filed 2025-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |